InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,010.60
(
0.87%
)
US TECH 100
16,724.00
(
0.83%
)
Dow Jones
38,239.98
(
0.67%
)
Brent Oil
86.36
(
-0.06%
)
Bitcoin
66,574.98
(
-0.42%
)
Post# of 251562
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Double_Bagel

Send PM Follow Ignore
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Double_Bagel

Re: None

Friday, 12/18/2015 7:16:33 AM

Friday, December 18, 2015 7:16:33 AM

Post# of 251562
http://finance.yahoo.com/news/uniqure-appoints-dan-soland-chief-113000949.html?soc_src=mediacontentstory&soc_trk=tw

uniQure Appoints Dan Soland as Chief Executive Officer


AMSTERDAM, the Netherlands, Dec. 18, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (QURE), a leader in human gene therapy, today announced the appointment of Dan Soland as the new Chief Executive Officer of the Company. Mr. Soland will succeed Jorn Aldag, who has decided to step down as CEO, a role he has held since 2009. Mr. Soland will also be nominated for appointment to uniQure's Management Board, subject to approval by the Company's General Meeting of Shareholders. Mr. Aldag will be available to assist the Company during the transition.



This can't be good news before the Hemophilia data release in January.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up